Physician profile

Ming Zhang

Interventional Cardiology · Seattle, WA

NPI 1164614731

$42,639.33

in general payments reported to CMS, 2019-2025

24 companies · $6,179 in 2025

The $6,179 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,911.68
Travel and Lodging$10,755.19
Consulting Fee$5,260.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$3,820.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $19,065.59 2019-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve
Abbott Laboratories $7,640.39 2019-2025 Amplatzer Amulet, Mitraclip, Cardiomems
Boston Scientific Corporation $4,033.12 2019-2025 Sentinel, Watchman Flx, Watchman
Siemens Medical Solutions USA, INC. $4,009.11 2020-2024 Acuson Sequoia Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System
Abiomed $2,579.84 2022-2025 Impella
Angiodynamics, INC. $2,409.00 2023-2025 Angiovac
Medtronic Vascular, INC. $582.16 2019
Medtronic, INC. $541.57 2023-2025 Avalus, Symplicity G3, Corevalve Evolut R
Shockwave Medical, INC $351.72 2023-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Actelion Pharmaceuticals US, INC. $266.99 2025 Uptravi, Opsumit
Ge Healthcare $168.98 2023-2024
Pfizer INC. $157.51 2025
Merck Sharp & Dohme LLC $149.96 2022-2025 Winrevair
Nevro Corp. $102.96 2019
E.R. Squibb & Sons, L.L.C. $86.21 2023 Camzyos
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $77.51 2025
Irhythm Technologies, INC. $76.63 2024 Zio Xt Patch, Zio Monitor
Novartis Pharmaceuticals Corporation $74.96 2024-2025
United Therapeutics Corporation $68.99 2025 Remodulin
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $63.49 2024-2025 Lifevest
Inari Medical, INC. $61.72 2020
Teleflex LLC $37.76 2022
Janssen Scientific Affairs, LLC $33.16 2023 Xarelto

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ming Zhang

$42,639.33

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $6,179 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/710172/ming-zhang

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.